tirzepatide and kidney damage 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve function in patients with obesity, chronic kidney disease (CKD), heart failure with preserved ejection fraction ( Tirzepatide ameliorates cisplatin-induced acute kidney

Most patients on semaglutide therapy begin noticing appetite changes within days, with measurable weight loss typically appearing in the first 4 weeks of treatment

To assess the realworld effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in ...

Prioritize sleep & stress management Poor sleep and chronic stress can affect hunger hormones and cravings

Learn how these treatments work and start a consultation through Forest Park Pharmacy.

Denied insurance coverage for GLP-1s